Sep 2026
Multiplexed FRET-FLIM Profiling of Immune Checkpoint Interactions Predicts Response to Atezolizumab in Urothelial Carcinoma
L. Camacho, C. Cacho-Navas, J. AguÌero et al.
· medRxiv · 0 citations
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Jul 2026
Immune checkpoint crosstalk: CTLA-4/CD80 engagement as a predictor of anti-PD-1/PD-L1 therapy outcome in NSCLC
Background CTLA-4/CD80 and PD-1/PD-L1 immune checkpoint pathways play critical roles in regulating T-cell activity within the tumor microenvironment (TME) of non-small cell lung cancer (NSCLC). While immune checkpoint inhibitors (ICIs) targeting PD-1/PD-L1 have improved survival outcomes, response rates vary, and predi...
J. Gumuzio, J. Miles, Nicole Quimi et al.
· Frontiers in Immunology · 1 citation